These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 3541826

  • 1. [Prevention of vasospasm following subarachnoid hemorrhage using a thromboxane A2 synthetase inhibitor (OKY-046)--clinical study among multiple institutions].
    Yonekawa Y, Handa H, Okamoto S, Ohta T, Kamijo Y, Oda Y, Kondo A, Nin K, Yamamoto T, Ban S.
    Nihon Geka Hokan; 1986 May 01; 55(3):473-84. PubMed ID: 3541826
    [No Abstract] [Full Text] [Related]

  • 2. [Experimental study on the prevention of vasospasm following subarachnoid hemorrhage by a thromboxane A2 synthetase inhibitor, OKY-046].
    Ohsugi S.
    Nihon Geka Hokan; 1986 Mar 01; 55(2):297-305. PubMed ID: 3827476
    [No Abstract] [Full Text] [Related]

  • 3. Prevention of cerebral vasospasm after SAH with a thromboxane synthetase inhibitor, OKY-1581.
    Sasaki T, Wakai S, Asano T, Takakura K, Sano K.
    J Neurosurg; 1982 Jul 01; 57(1):74-82. PubMed ID: 7201009
    [Abstract] [Full Text] [Related]

  • 4. Effect of selective inhibitor of thromboxane A2 synthetase on cerebral vasospasm after early surgery.
    Tani E, Maeda Y, Fukumori T, Nakano M, Kochi N, Morimura T, Yokota M, Matsumoto T.
    J Neurosurg; 1984 Jul 01; 61(1):24-9. PubMed ID: 6539367
    [Abstract] [Full Text] [Related]

  • 5. Prevention of cerebral vasospasm with OKY-046 an imidazole derivative and a thromboxane synthetase inhibitor. A preliminary co-operative clinical study.
    Suzuki S, Iwabuchi T, Tanaka T, Kanayama S, Ottomo M, Hatanaka M, Aihara H.
    Acta Neurochir (Wien); 1985 Jul 01; 77(3-4):133-41. PubMed ID: 2933930
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Combination of serine protease inhibitor FUT-175 and thromboxane synthetase inhibitor OKY-046 decreases cerebral vasospasm in patients with subarachnoid hemorrhage.
    Kaminogo M, Yonekura M, Onizuka M, Yasunaga A, Shibata S.
    Neurol Med Chir (Tokyo); 1998 Nov 01; 38(11):704-8; discussion 708-9. PubMed ID: 9919901
    [Abstract] [Full Text] [Related]

  • 8. The role of the prostacyclin-thromboxane system in cerebral vasospasm following induced subarachnoid hemorrhage in the rabbit.
    Chan RC, Durity FA, Thompson GB, Nugent RA, Kendall M.
    J Neurosurg; 1984 Dec 01; 61(6):1120-8. PubMed ID: 6389786
    [Abstract] [Full Text] [Related]

  • 9. [Protective effect of a thromboxane synthetase inhibitor, OKY-046, in patients with acute respiratory failure].
    Sakio H, Usui Y, Mita H, Onoda N, Iida M, Okuda C.
    Masui; 1984 Sep 01; 33(9):964-9. PubMed ID: 6542601
    [No Abstract] [Full Text] [Related]

  • 10. Clinical study on effect of thromboxane A2 synthetase inhibitor (OKY-046) to clarify the regulation of cerebral blood flow in cerebral thrombosis.
    Nihei C, Metoki H, Shimanaka Y, Kawahara R, Komatsu O, Oike Y, Kanazawa T, Izawa M, Kaneko H, Hoshi Y.
    Adv Prostaglandin Thromboxane Leukot Res; 1987 Sep 01; 17B():953-7. PubMed ID: 2960210
    [No Abstract] [Full Text] [Related]

  • 11. Prostacyclin and thromboxane in cerebral vasospasm II: Effects of thromboxane synthetase inhibitor (OKY-1581) on experimentally-induced cerebral vasospasm.
    Yabuno N.
    Acta Med Okayama; 1984 Jun 01; 38(3):239-50. PubMed ID: 6380217
    [Abstract] [Full Text] [Related]

  • 12. Clinical study of OKY-046, a thromboxane synthetase inhibitor, in prevention of cerebral vasospasms and delayed cerebral ischaemic symptoms after subarachnoid haemorrhage due to aneurysmal rupture: a randomized double-blind study.
    Suzuki S, Sano K, Handa H, Asano T, Tamura A, Yonekawa Y, Ono H, Tachibana N, Hanaoka K.
    Neurol Res; 1989 Jun 01; 11(2):79-88. PubMed ID: 2569686
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and toxicity of thromboxane synthetase inhibitor for cerebral vasospasm after subarachnoid hemorrhage.
    Tokiyoshi K, Ohnishi T, Nii Y.
    Surg Neurol; 1991 Aug 01; 36(2):112-8. PubMed ID: 1891755
    [Abstract] [Full Text] [Related]

  • 14. [Thromboxane A2 metabolism and clinical effects of selective thromboxane A2 synthetase inhibitor in patients with chronic glomerulonephritis].
    Niwa T, Nomura T, Ozawa Y, Maeda K, Shibata M.
    Nihon Jinzo Gakkai Shi; 1987 Jun 01; 29(6):655-65. PubMed ID: 3682335
    [No Abstract] [Full Text] [Related]

  • 15. [Effects of a selective thromboxane A2 synthetase inhibitor, OKY-046, on proteinuria of aminonucleoside nephrotic rats].
    Suzuki S, Akama H, Kume K, Higuchi E, Kamiyama S, Suzuki J, Ohara N, Yugeta E, Kato K, Suzuki H.
    Nihon Jinzo Gakkai Shi; 1988 Apr 01; 30(4):341-6. PubMed ID: 3230687
    [No Abstract] [Full Text] [Related]

  • 16. Clinical effects of selective thromboxane A2 synthetase inhibitor in patients with nephrotic syndrome.
    Niwa T, Maeda K, Shibata M, Yamada K.
    Clin Nephrol; 1988 Nov 01; 30(5):276-81. PubMed ID: 3214971
    [Abstract] [Full Text] [Related]

  • 17. Selective thromboxane synthetase inhibitor and ischemic heart disease.
    Ito T, Ogawa K, Watanabe J, Chen LS, Shikano M, Imaizumi M, Shibata T, Ito Y, Miyazaki Y, Satake T.
    Biomed Biochim Acta; 1984 Nov 01; 43(8-9):S125-32. PubMed ID: 6542777
    [No Abstract] [Full Text] [Related]

  • 18. [A double-blind placebo-controlled study of OKY-046 in the treatment of chronic asthma].
    Kabe J.
    Nihon Naika Gakkai Zasshi; 1989 Sep 01; 78(9):1288-92. PubMed ID: 2687415
    [No Abstract] [Full Text] [Related]

  • 19. Effects of selective thromboxane synthetase inhibitor OKY-046 on plasma prostaglandins in patients with coronary artery disease during exercise.
    Shikano M, Ogawa K, Ito T, Chen LS, Ito Y, Imaizumi M, Uno T, Tsutsumi S, Satake T.
    Adv Prostaglandin Thromboxane Leukot Res; 1985 Sep 01; 13():375-7. PubMed ID: 3159226
    [No Abstract] [Full Text] [Related]

  • 20. [The efficacy of prostacyclin (PGI2) and/or OKY-046, a specific thromboxane synthetase inhibitor, in acute myocardial infarction--experimental study].
    Moriuchi M.
    Kokyu To Junkan; 1984 Sep 01; 32(9):955-61. PubMed ID: 6393261
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.